George Ghareeb, MD
Urology · Grand Rapids, MINPI 1528403235
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $11,080 of the $15,808 with a category attached, or 70.1%. Boston Scientific accounts for 97.7% of it on its own, with 8 other manufacturers making up the rest. 2025 is the largest year on record at $11,632, more than ten times the $190 reported in 2019.
Across 90 payments — averaging $175.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$15K
- Teleflex LLC$109
- Boehringer Ingelheim$88
- Neotract Inc.$54
- Bayer$39
- Siemens Medical Solutions USA, Inc.$20
- plus $48 from 3 others
What the payments were for
- Speaking & faculty fees$11,08070%
- Travel & lodging$1,74711%
- Food & beverage$2,98219%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 77 | $15,451 |
| Teleflex LLC | 1 | $109 |
| Boehringer Ingelheim | 4 | $88 |
| Neotract Inc. | 2 | $54 |
| Bayer | 2 | $39 |
| Siemens Medical Solutions USA, Inc. | 1 | $20 |
| Abbott | 1 | $19 |
| Endo Pharmaceuticals Inc. | 1 | $15 |
| E.r. Squibb & Sons, L.L.C. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AdVance XP$11,080
- AMS 700$1,581
- GENERAL ERECTILE DYSFUNCTION$129
- UroLift System$109
How this compares
$15,808 in reported general payments places this provider in the 85th percentile of 400 urology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 142 | $68,966 |
| Trospium Chloride ErTrospium Chloride | 12 | $4,347 |
| Tamsulosin Hcl | 162 | $3,068 |
| Finasteride | 129 | $2,567 |
| Oxybutynin Chloride ErOxybutynin Chloride | 113 | $2,517 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 27 | $874 |
| Solifenacin Succinate | 11 | $544 |
| Desmopressin Acetate | 31 | $505 |
| Tadalafil | 12 | $391 |
| Oxybutynin Chloride | 13 | $142 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 54 | $114 |
Paid to pharmacies, not to this prescriber.
Other urology in Grand Rapids
- Phillip WiseGrand Rapids$28K
- John AnemaGrand Rapids$24K
- Christopher BredeGrand Rapids$14K
- Ashok ReddySterling Heights$4.9M
- William RobertsAnn Arbor$973K
- Kenneth KernenTroy$910K
- William JohnstonLivonia$675K
- Jason HafronWest Bloomfield$490K
- Khurshid GhaniAnn Arbor$413K
- Richard BennettRoyal Oak$361K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.